Melanoma Clinical Trials

Showing 761-780 of 1,477 trials

Safety and Efficacy of AK104, a PD-1/CTLA-4 Bispecific Antibody, in Selected Advanced Solid Tumors

NCT04172454

A multicenter, open-label, phase 1b/2 study to evaluate the safety and efficacy of AK104, a PD-1 and CTLA-4 bispecific antibody, in selected advanced solid tumors.

Advanced Solid TumorsMelanoma

Akeso68 participantsStarted Dec 2019

Guangzhou, Guangdong, China

COMPLETEDPhase 2

Study of NY-ESO-1 ISCOMATRIX® in Patients With High-risk, Resected Melanoma

NCT00199901

The purpose of this trial is to assess whether treatment with NY-ESO-1 ISCOMATRIX® vaccine improves outcomes for people with Malignant Melanoma which has been removed, but is at high risk of relapse.

Melanoma

Ludwig Institute for Cancer Research111 participantsStarted Sep 2005

Camperdown, New South Wales, Australia • Newcastle, New South Wales, Australia • Woolloongabba, Queensland, Australia +12 more locations

Safety and Efficacy of AK104, a PD-1/CTLA-4 Bispecific Antibody, in Selected Advanced Solid Tumors

Study of NY-ESO-1 ISCOMATRIX® in Patients With High-risk, Resected Melanoma

Related Searches

Immunization With 8 Peptides Mixed With CpG 7909 or Montanide ISA51 in Patients With Metastatic Cutaneous Melanoma

A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas

A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma

A Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma Recurrence

Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy

Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery

Sentinel Lymph Node Mapping Using Magtrace and MRI in Healthy Subjects for Potential Use in Melanoma Patients

Early Complications After Axillary and Inguinal Lymph Node Dissection in Stage III Melanoma Patients

pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma

Phase I/II Study of PDR001 in Patients With Advanced Malignancies

A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors

A Study of PLX2853 in Advanced Malignancies.

Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer

A Pilot Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes

Sentinel Lymph Node Detection in Patients With Stage Ib-III Melanoma Using MSOT and ICG

Conservative Nodal Surgery (Node-picking) of Patients With Stage III Melanoma With Low-burden of Nodal Disease (MELCONSURG MULTICENTRE COHORT)

Study of PI-88 in Patients With Advanced Melanoma

A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma